Home pagePress monitoringEkso Bionics(R) to Establish Headquarters in Freiburg,...

Ekso Bionics(R) to Establish Headquarters in Freiburg, Germany; Strengthens European Expansion Efforts

Date: 12.11.2015 

RICHMOND, Calif., Nov. 12, 2015 (GLOBE NEWSWIRE) - Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a leading global robotic exoskeleton company, announced today that it has established a new regional headquarters, based in Freiburg, Germany, to further strengthen its European presence and better serve German-speaking markets. The expansion is being led by Ruediger Hausherr, President, EMEA, Ekso Bionics, and marks an integral step in the company's development of its Europe, Middle East, and Africa (EMEA) business.

"Establishing this Germany-based subsidiary will allow us to enhance our customer service with training, education, and field service support by being in closer proximity to our valued customers," said Hausherr. "The Freiburg headquarters will also position Ekso to build strategic partnerships in the area."

This new site further supports Ekso Bionics' European operations by facilitating regional growth plans, establishing a dedicated sales and customer service organization to more closely liaise with leading rehabilitation centers in the region including existing customers such as Swiss Paraplegic Centre (SPC), Uppsala University Hospital, Sunnaas Hospital, BG Clinics and Schön Klinik Bad Aibling to name a few.

"We are excited to further expand our European business to meet a rise in demand for our advanced technology," said Thomas Looby, President and Chief Commercial Officer of Ekso Bionics. "I am pleased to see how Ruediger and the EMEA team have strengthened our business since he joined us in early October. Our presence in Western Europe is a strategic part of our market development and demonstrates our commitment to operational excellence."

About Ekso Bionics

Since 2005, Ekso Bionics has been pioneering the field of robotic exoskeletons, or wearable robots, to augment human strength, endurance and mobility. The company's first commercially available product called Ekso has helped thousands of people living with paralysis take millions of steps not otherwise possible. By designing and creating some of the most forward-thinking and innovative solutions for people looking to augment human capabilities, Ekso Bionics is helping people rethink current physical limitations and achieve the remarkable. Ekso Bionics is headquartered in Richmond, CA and is listed on the OTC QB under the symbol EKSO. www.eksobionics.com


CONTACT: 
Media Contact: Heidi Darling, Director of Marketing Communications Phone: 510-984-1761 x317 E-mail: hdarling@eksobionics.com
Investor Contact: Chad Rubin, Senior Vice President Phone: 646-378-2947 E-mail: crubin@troutgroup.com

 


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. 

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Ekso Bionics via GlobeNewswire
HUG#1966301

 

OPPI, MPO, EU

CEBIO

  • CEBIO
  • BC AV CR
  • Budvar
  • CAVD
  • CZBA
  • Eco Tend
  • Envisan Gem
  • Gentrend
  • JAIP
  • Jihočeská univerzita
  • Madeta
  • Forestina
  • ALIDEA

LinkedIn
TOPlist